Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection

Journal of Neuroscience

Volumn 23, Issue 25, 2003, Pages 8701-8705

  McCullough, Louise D ^a   Blizzard, Kathleen ^a   Simpson, Evan R ^d   Öz, Orhan K ^b   Hurn, Patricia D ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Johns Hopkins Univ Sch of Medicine ^*

Author keywords

Aromatase; Estrogen; Gender; Ischemia; Neuroprotection; Stroke

Indexed keywords

AROMATASE; CYTOCHROME P450; DNA; ESTRADIOL; ESTROGEN; FADROZOLE; NEUROPROTECTIVE AGENT; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AROMATIZATION; ARTICLE; BLOOD PRESSURE; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE PREDISPOSITION; ESTROGEN SYNTHESIS; FEMALE; HISTOPATHOLOGY; KNOCKOUT MOUSE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; STROKE;

EID: 0141535178     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-25-08701.2003     Document Type: Article

References (36)

1. Agarwal VR, Sinton CM, Liang C, Fisher C, German DC, Simpson ER (2000) Upregulation of estrogen receptors in the forebrain of aromatase knock-out (ArKO) mice. Mol Cell Endocrinol 162:9-16.
2. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD (1998) Gender-linked brain injury in experimental stroke. Stroke 29:159-165.
3. Alkayed NJ, Murphy SJ, Traystman RJ, Hurn PD, Miller VM (2000) Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 31:161-168.
4. Azcoitia I, Sierra A, Veiga S, Honda S, Harada N, Garcia-Segura LM (2001) Brain aromatase is neuroprotective. J Neurobiol 47:318-329.
5. Bakker J, Honda S, Harada N, Balthazart J (2002) The aromatase knock-out mouse provides new evidence that estradiol is required during development in the female for the expression of sociosexual behaviors in adulthood. J Neurosci 22:9104-9112.
6. Balthazart J, Ball GF (1998) New insights into the regulation and function of brain estrogen synthase (aromatase). Trends Neurosci 21:243-249.
7. Balthazart J, Baillien M, Ball GF (2001) Phosphorylation processes mediate rapid changes of brain aromatase activity, J Steroid Biochem Mol Biol 79:261-277.
8. Bonsall RW, Clancy AN, Michael RP (1992) Effects of the non-steroidal aromatase inhibitor, fadrozole on sexual behavior in male rats. Horm Behav 26:240-254.
9. Bulun SE, Zeitoun K, Sasano H, Simpson ER (1999) Aromatase in aging women. Semin Reprod Endocrinol 17:349-358.
10. Carswell HV, Dominiczak AF, Macrae IM (2000) Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 278:H290-H294.
11. Clancy AN, Michael RP (1994) Effects of testosterone and aromatase inhibition on estrogen receptor-like immunoreactivity in male rat brain. Neuroendocrinology 59:553-560.
12. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM (2001) Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 98:1952-1957.
13. Fisher CR, Graves KH, Parlow AF, Simpson ER (1998) Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp 19 gene. Proc Natl Acad Sci USA 95:6965-6970.
14. Garcia-Segura LM, Wozniak A, Azcoitia I, Rodriguez JR, Hutchison RE, Hutchison JB (1999) Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience 89:567-578.
15. Hammond J, Le Q, Goodyer C, Gelfand M, Trifiro M, LeBlanc A (2001) Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J Neurochem 77:1319-1326.
16. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735-12740.
17. Kamat A, Hinshelwood MM, Murry BA, Mendelson CR (2002) Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab 13:122-128.
18. Lephart ED (1996) A review of brain aromatase cytochrome P450. Brain Res Rev 22:1-26.
19. Lephart ED, Lund TD, Horvath TL (2001) Brain androgen and progesterone metabolizing enzymes: biosynthesis, distribution and function. Brain Res Rev 37:25-37.
20. MacLusky NJ, Walters MJ, Clark AS, Toran-Allerand CD (1994) Aromatase in the cerebral cortex, hippocampus, and midbrian: ontogeny and developmental implications. Mol Cell Neurosci 5:691-698.
21. McCullough LD, Hurn PD (2003) Estrogen and neuroprotection: an integrated view. Trends Endocrinol Metab 14:228-235.
22. McCullough LD, Alkayed NJ, Traystman RJ, Williams MJ, Hurn PD (2001) Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 32:796-802.
23. Misso ML, Murata Y, Boon WC, Jones ME, Britt KL, Simpson ER (2003) Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 144:1474-1480.
24. Oz OK, Zerwekh JE, Fisher C, Graves K, Nanu L, Millsaps R, Simpson ER (2000) Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res 15:507-514.
25. Robertson KM, O'Donnell L, Jones ME, Meachem SJ, Boon WC, Fisher CR, Graves KH, McLachlan RI, Simpson ER (1999) Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci USA 96:7986-7991.
26. Rusa R, Alkayed NJ, Crain BJ, Traystman RJ, Kimes AS, London ED, Klaus JA, Hurn PD (1999) 17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 30:1665-1670.
27. Sampei K, Goto S, Alkayed NJ, Crain BJ, Korach KS, Traystman RJ, Demas GE, Nelson RJ, Hurn PD (2000) Stroke in estrogen receptor-alpha-deficient mice. Stroke 31:738-743.
28. Sawada M, Alkayed NJ, Goto S, Crain BJ, Traystman RJ, Shaivitz A, Nelson RJ, Hurn PD (2000) Estrogen receptor antagonist ICI152, 780 exacerbates ischemic injury in female mouse. J Cereb Blood Flow Metab 20:112-115.
29. Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, Speed C, Jones M (2002) Aromatase - a brief overview. Annu Rev Physiol 64:93-127.
30. Steele RE, Mellor LB, Sawyer WK, Wasvary JM, Browne LJ (1987) In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A. Steroids 50:147-161.
31. Stoffel-Wagner B, Watzka M, Schramm J, Bidlingmaier F, Klingmuller D (1999) Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J Steroid Biochem Mol Biol 70:237-241.
32. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI (2001) A clinical trial of estrogen-replacement therapy after ischemic stroke. New Engl J Med 345:1243-1249.
33. Wade J, Schlinger BA, Hodges L, Arnold AP (1994) Fadrozole: potent and specific inhibitor of aromatase in the zebra finch brain. Gen Comp Endocrinol 94:53-61.
34. Wozniak A, Holman SD, Hutchinson JB (1992) In vitro potency and selectivity of the nonsteroidal androgen aromatase inhibitor CGS 16949A compared to steroidal inhibitors in the brain. J Steroid Biochem Mol Biol 43:281-287.
35. Writing Group for the Women's Health Initiative (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333.
36. Zumpe D, Bonsall RW, Michael RP (1993) Effects of the nonsteroidal aromatase inhibitor, fadrozole, on the sexual behavior of male Cynomolgus monkeys (Macaca fasicicularis). Hormones Behav 27:200-215.